Odyssey Therapeutics, Inc.
NASDAQ:ODTXBiotechnology
-$0.01 today
- Market cap
- $912.33M
- Beta
- 0.00
Volume 0.37M
Average 0.43M
ODTX Other Current Liabilities
Short-term obligations not reported separately, such as accrued expenses.
Other Current Liabilities history
Currency unavailable · from the balance sheet
No Other Current Liabilities data reported for this period type.
Other Current Liabilities vs competitors
How ODTX compares with its peers on the latest reported figures
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
ALMSAlumis Inc. Common Stock | Jun 2026 | $51.94M USD | +304.3% | +151.8% | 9.3% |
| Sep 2026 | $40.14M USD | +145.9% | +84.6% | 3.7% | |
| Mar 2026 | $26.53M USD | +408.5% | +27.3% | 8.0% | |
| Jun 2026 | $16.02M USD | +220.0% | +46.1% | 1.8% | |
| Mar 2026 | $6.06M USD | -39.9% | -8.8% | 3.0% | |
| Mar 2026 | $5.53M USD | +323.0% | +39.7% | 2.9% | |
ORKAOruka Therapeutics, Inc. | Sep 2026 | $50K USD | -99.7% | +117.0% | 0.0% |
AGMBAgomAb Therapeutics N.V. American Depositary Shares | Sep 2025 | €0 EUR | — | — | 0.0% |
ODTXOdyssey Therapeutics, Inc. | — | — | — | — | — |
| Peer median (excluding ODTX) | — | +220.0% | +46.1% | 3.0% | |
Competitors are the stored peer set for ODTX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Odyssey Therapeutics, Inc.
NASDAQ:ODTX
Intrinsic Alpha fair value
Locked
Current Price
$18.98
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.